Cargando…
Use of (18)F FDG PET and the short temporal response of Hodgkin's disease to RIT
Radioimmunotherapy (RIT) has been available for some time to treat patients with non-Hodgkin's lymphoma, but its use in Hodgkin's lymphoma has been less available, partly because of the need to find an appropriate antibody. A new radioiodinated chimeric antibody directed against the CD25 e...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034536/ https://www.ncbi.nlm.nih.gov/pubmed/30034281 http://dx.doi.org/10.4103/wjnm.WJNM_50_17 |